Abstract
Two Palladium complexes are presented as a promising alternative to platinum drugs disadvantages, controlling the speciation and limiting toxicity. Their interaction vs. biological targets and their efficiency are demonstrated, being more specific than the benchmark cisplatin drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have